Skip to main content
Caplight Logo









Phosphoenix

Phosphoenix

Private
AmsterdamHealthcare & Life Scienceshttps://www.phosphoenix.nl/

Last Round

Convertible Debt

Apr 30, 2025

Total Funding Raised

$2.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Phosphoenix is a MedTech company that develops brain-computer interface technology and visual prostheses to restore functional vision for blind individuals.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

brain prosthesisvisual prosthesisneuroprosthetic devicebionic eyebrain-computer interfaceBCIimplantable electrodeneural implantartificial visionneurotechnologymedical deviceimage processing algorithmsblindness treatmentdeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phosphoenix Comparables

Compare Phosphoenix with similar companies based on industry and business-model similarity.

Phosphoenix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ReVision Implant
92%
Vivani Medical
82%
Neuralink
77%

Phosphoenix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtApr 30, 2025
GrantJan 15, 2025
SeedDec 11, 2024
Pre SeedSep 22, 2022

Key People

Founding team and executive leadership

Hans Brons

CEO

Executive Team

Bert Monna

CTO

Executive Team

Phosphoenix Investors

Notable investors and investment history

Phosphoenix investors
InvestorRounds
European Innovation Council FundGrant
Innovatiefonds Noord-HollandConvertible Debt, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Grew 18% QoQ from 17 to 20 employees.

  • Feb 7, 2026

    Grew 27% QoQ, from 15 to 19 employees.

Phosphoenix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phosphoenix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phosphoenix's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam
Employee Range20
Year Founded2019
Last FundingApr 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?